BioXcel Therapeutics Announces Pricing of $7.0 Million

21 hours ago · BioXcel Therapeutics Announces Pricing of $7.0 Million Public Offering ... today announced the pricing of an underwritten public offering of 5,600,000 shares of its common stock, par value $0.001 ...

CouponFollow Extension

$7
OFF

BioXcel Therapeutics Announces Pricing Of $7.0 Million

6 days from now

globenewswire.com

$7
OFF

BioXcel Therapeutics Announces Pricing Of $7.0 Million Public …

6 days from now

21 hours ago · Each of the accompanying warrants will have an exercise price of $0.48 per underlying share of Common Stock. Canaccord Genuity is acting as sole book-running …

yahoo.com

$7
OFF

BioXcel Therapeutics Announces Pricing Of $7M Public Offering

6 days from now

21 hours ago · BioXcel Therapeutics announces pricing of public offering at $0.48 per share, grossing $7 million.

seekingalpha.com

$7
OFF

BioXcel Therapeutics Announces Pricing Of $7M Public Offering

6 days from now

BioXcel Therapeutics (NASDAQ:BTAI) on Friday announced the pricing of an underwritten public offering of 5.6M shares of its common stock and accompanying warrants to purchase up to …

msn.com

$7
OFF

BioXcel Therapeutics Announces Pricing Of $7.0 Million Public …

6 days from now

1 day ago · NEW HAVEN, Conn., Nov. 22, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (the “Company&CloseCurlyDoubleQuote;) (Nasdaq: BTAI), a biopharmaceutical company …

stockhouse.com

$7
OFF

BioXcel Therapeutics Prices Of $7 Million Public Offering

6 days from now

1 day ago · NEW HAVEN, Conn., Nov. 22, 2024 (GLOBE NEWSWIRE) — BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence approaches to …

citybiz.co

$7
OFF

BioXcel Therapeutics (BTAI) Announces Pricing Of $7.0 Million …

6 days from now

21 hours ago · BioXcel Therapeutics (BTAI) Announces Pricing of $7.0 Million Public Offering ... today announced the pricing of an underwritten public offering of 5,600,000 shares of its …

streetinsider.com

$7
OFF

BioXcel Therapeutics Announces Pricing Of $7.0 Million Public …

6 days from now

NEW HAVEN, Conn., Nov. 22, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (the “Company”) (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence …

bioxceltherapeutics.com

$7
OFF

BioXcel Therapeutics Announces Pricing Of $7.0 Million Public Of

6 days from now

NEW HAVEN, Conn., Nov. 22, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (the â Companyâ ) ( BTAI), a biopharmaceutical company utilizing artificial i 🚀 Enjoy a 7-Day Free …

gurufocus.com

$7
OFF

BioXcel Therapeutics Announces $7M Public Offering

6 days from now

19 hours ago · The company said its underwritten public offering of 5.6 million shares of its common stock, with a par value of $0.001 per share, and accompanying warrants to purchase …

hartfordbusiness.com

$7
OFF

BioXcel Therapeutics Announces Pricing Of $7.0 Million Public …

6 days from now

21 hours ago · BioXcel Therapeutics (BTAI) has announced the pricing of a $7.0 million public offering, consisting of 5,600,000 shares of common stock and warrants to purchase up to …

stocktitan.net

$9
OFF

BioXcel Therapeutics Announces Proposed Public Offering

6 days from now

Feb 8, 2024 · In addition, the Company expects to grant the underwriters a 30-day option to purchase up to $9.0 million of additional shares of common stock at the public offering price, …

yahoo.com

$7
OFF

BioXcel Therapeutics Announces Pricing Of $7.0 Million Public …

6 days from now

NEW HAVEN, Conn., Nov. 22, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (the "Company") (NASDAQ:BTAI), a biopharmaceutical company utilizing artificial intelligence …

quantisnow.com

$7
OFF

BioXcel Therapeutics Announces Pricing Of $7.0 Million Public …

6 days from now

21 hours ago · BioXcel Therapeutics Announces Pricing of $7.0 Million Public Offering. ... today announced the pricing of an underwritten public offering of 5,600,000 shares of its common …

einnews.com

$0.00
OFF

BioXcel Therapeutics Prices 5.6M Shares At 48c In Public Offering

6 days from now

1 day ago · BioXcel Therapeutics announced the pricing of an underwritten public offering of 5,600,000 shares of its common stock, par value $0.001 per share and accompanying …

businessinsider.com

$7
OFF

BioXcel Therapeutics Announces Pricing Of $7.0 Million Public

6 days from now

BTAI BioXcel Therapeutics Inc BioXcel Therapeutics Announces Pricing of $7.0 Million Public Offering. NEW HAVEN, Conn., Nov. 22, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, …

advfn.com

$7
OFF

BioXcel Therapeutics Announces Pricing Of $7.0 Million Public …

6 days from now

21 hours ago · NEW HAVEN, Conn., Nov. 22, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (the "Company”) (Nasdaq: BTAI), a biopharmaceutical company utilizing …

manilatimes.net

FAQs about BioXcel Therapeutics Announces Pricing of $7.0 Million Coupon?

Who owns bioxcel Therapeutics?

Private Companies own 31% of the shares in BioXcel Therapeutics, Inc. (NASDAQ:BTAI). The general public holds a 24% stake in the company, but they may not have enough influence to sway policy decisions. ...

How much did bioxcel Therapeutics raise in an IPO?

BioXcel Therapeutics (BTAI) raised $60 million in their IPO on Thursday, March 8th 2018. The company issued 5,000,000 shares at a price of $11.00-$13.00 per share. $60 million was raised in the IPO. ...

What was the closing price of bioxcel Therapeutics Inc registered SHS?

On Thursday 08/22/2024 the closing price of the BioXcel Therapeutics Inc Registered Shs share was $0.65 on BTT. Compared to the opening price on Thursday 08/22/2024 on BTT of $0.67, this is a drop of 2.47%. BioXcel Therapeutics Inc Registered Shs's market capitalization is $27.14 M by 40.74 M shares outstanding. ...

Will BioXcel Therapeutics lose value?

If things turn out that way, BioXcel Therapeutics will lose a substantial percentage of its value. We will know soon enough whether this is the case and if the company's ongoing launch of Igalmi in its current indication could come short of expectations. ...

What is the debt level of BioXcel Therapeutics?

A higher level of debt in BioXcel Therapeutics' case amounts to 73% of its equity. Generally, the rule of thumb is debt shouldn’t exceed 40% of your equity, which increases the risk around investing in a loss-making company. ...

Is BioXcel Therapeutics a risky stock?

BioXcel Therapeutics is a risky stock despite its massive potential upside. Biotech companies rarely win every clinical or regulatory battle they face, and if the company fails in even one important aspect, its shares will likely plunge. Only those investors comfortable with this risk should consider initiating a position. ...